IFOSFAMIDE Drug Patent Profile
✉ Email this page to a colleague
When do Ifosfamide patents expire, and what generic alternatives are available?
Ifosfamide is a drug marketed by Fresenius Kabi Usa, Hikma, Meitheal, Rising, and Teva Pharms Usa. and is included in six NDAs.
The generic ingredient in IFOSFAMIDE is ifosfamide; mesna. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ifosfamide; mesna profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for IFOSFAMIDE?
- What are the global sales for IFOSFAMIDE?
- What is Average Wholesale Price for IFOSFAMIDE?
Summary for IFOSFAMIDE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 130 |
| Clinical Trials: | 456 |
| Patent Applications: | 3,775 |
| Drug Prices: | Drug price information for IFOSFAMIDE |
| What excipients (inactive ingredients) are in IFOSFAMIDE? | IFOSFAMIDE excipients list |
| DailyMed Link: | IFOSFAMIDE at DailyMed |
Recent Clinical Trials for IFOSFAMIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| BeBetter Med Inc | Phase 1 |
| Exelixis | Phase 1 |
| Children's Hospital Colorado | Phase 1 |
Pharmacology for IFOSFAMIDE
| Drug Class | Alkylating Drug |
| Mechanism of Action | Alkylating Activity |
Medical Subject Heading (MeSH) Categories for IFOSFAMIDE
Anatomical Therapeutic Chemical (ATC) Classes for IFOSFAMIDE
US Patents and Regulatory Information for IFOSFAMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | IFOSFAMIDE | ifosfamide | INJECTABLE;INJECTION | 076078-001 | May 28, 2002 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Meitheal | IFOSFAMIDE | ifosfamide | INJECTABLE;INJECTION | 076657-001 | Apr 4, 2007 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fresenius Kabi Usa | IFOSFAMIDE | ifosfamide | INJECTABLE;INJECTION | 090181-002 | Sep 22, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Pharms Usa | IFOSFAMIDE/MESNA KIT | ifosfamide; mesna | INJECTABLE;INTRAVENOUS | 075874-002 | Feb 26, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Meitheal | IFOSFAMIDE | ifosfamide | INJECTABLE;INJECTION | 076657-002 | Apr 4, 2007 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fresenius Kabi Usa | IFOSFAMIDE | ifosfamide | INJECTABLE;INJECTION | 090181-001 | Sep 22, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fresenius Kabi Usa | IFOSFAMIDE | ifosfamide | INJECTABLE;INJECTION | 076078-002 | May 28, 2002 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
